PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma
Lisette Yco(University of Hawaii at Hilo), André S. Bachmann(Michigan State University)
Cited by 15
Related Papers
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma
|International Journal of Oncology|2013|56
Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
|Cancer Cell International|2018|48